Get Stock Quote Here The Boston Scientific Corporation (abbreviated BSC) is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urologyand gynecology. Boston Scientific is primarily known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator (ICD) which they call the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD). Boston Scientific's main competitors are Johnson and Johnson, Medtronic, St. Jude Medical, and the Abbott Vascular division of Abbott Laboratories.
Reported before open today (10/26/16) Earnings: EPS $0.27 Revenue $2.11B Estimates: EPS $0.27 Revenue $2.07B Down 1.56% today
Been coiling for weeks now. Above average volume today with marabozu candle (open=low and close=high, i.e. all green) as it looks to break through resistance.
This is just pulling off of a trendline connecting the lows going back to 2016 Weekly chart Daily chart: things have been volatile in general lately, but this stock has held up better than before. Back in December this dropped from 28.50 down to 24.75 with lots of supply (touching the trend line). Recently this dropped from 28.50 down to only 26.30 with much less supply, staying above the trend line. Would like to see this above the 20ma. Heck, it's even below the 200ma so that's not a good sign. It's 27.32 right now, so it's a low-risk entry time. Not one of those companies that will show up on the nightly news in a bad light.
